AstraZeneca (AZNCF)

AI Score

Unlock

132.38

-7.42 (-5.31%)

At close: Apr 21, 2025, 3:52 PM

AstraZeneca Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	5.49B	5.84B	6.17B	6.33B	7.83B	5.37B	4.83B	3.32B	5.02B
Short-Term Investments	166M	20M	239M	69M	160M	849M	849M	1.23B	884M
Long-Term Investments	1.73B	1.66B	903M	1.17B	987M	610M	73M	-194M	-58M
Other Long-Term Assets	1.28B	2.71B	1.15B	1.07B	1.05B	1.65B	1.52B	2.58B	2.13B
Receivables	n/a	8.41B	9.98B	8.78B	5.65B	5.18B	5.71B	2.8B	4.74B
Inventory	5.29B	5.42B	4.7B	8.98B	4.02B	3.19B	2.89B	3.04B	2.33B
Other Current Assets	14.88B	3.75B	3.11B	3.32B	1.94B	1.7B	3.08B	1.68B	2.31B
Total Current Assets	25.83B	25.05B	22.59B	26.24B	19.54B	15.56B	15.59B	13.15B	13.26B
Property-Plant & Equipment	11.65B	10.49B	9.45B	10.17B	8.92B	8.34B	7.42B	7.62B	6.85B
Goodwill & Intangibles	58.2B	58.14B	59.13B	62.38B	32.79B	32.5B	33.67B	38.01B	39.24B
Total Long-Term Assets	78.21B	76.06B	73.89B	79.12B	47.19B	45.81B	45.06B	50.2B	49.26B
Total Assets	104.03B	101.12B	96.48B	105.36B	66.73B	61.38B	60.65B	63.35B	62.53B
Account Payables	22.46B	3.27B	2.55B	2.82B	2.35B	1.77B	1.72B	2.29B	1.68B
Deferred Revenue	n/a	148.79M	181.98M	1.01B	1.63B	28M	218M	n/a	n/a
Short-Term Debt	2.16B	5.13B	6.27B	2.66B	2.23B	1.86B	1.78B	2.27B	2.24B
Other Current Liabilities	1.5B	5.98B	3.81B	4.52B	5.85B	4.9B	3.73B	4.21B	4B
Total Current Liabilities	27.87B	30.54B	26.29B	22.59B	20.31B	18.12B	16.29B	16.38B	15.26B
Long-Term Debt	26.51B	22.33B	23.91B	29.72B	19.8B	17.89B	19.2B	17.39B	16.51B
Other Long-Term Liabilities	4.37B	5.37B	8.5B	13.01B	10.49B	10.28B	11.11B	12.94B	14.08B
Total Long-Term Liabilities	35.3B	31.41B	33.13B	43.48B	30.78B	28.66B	30.32B	30.33B	30.6B
Total Liabilities	63.16B	61.95B	59.42B	66.08B	51.09B	46.78B	46.61B	46.71B	45.86B
Total Debt	30.11B	28.62B	29.23B	30.78B	20.38B	18.23B	19.11B	17.81B	16.81B
Common Stock	388M	388M	387M	387M	328M	328M	317M	317M	316M
Retained Earnings	3.16B	4.52B	-574M	1.71B	5.3B	2.81B	5.68B	8.22B	8.14B
Comprehensive Income	n/a	-949M	1.63B	1.59B	1.58B	1.6B	1.59B	1.58B	1.6B
Shareholders Equity	40.79B	39.14B	37.04B	39.27B	15.62B	13.13B	12.47B	14.96B	14.85B
Total Investments	1.9B	1.68B	1.14B	1.24B	1.15B	1.46B	922M	1.04B	826M